Jan 19 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA RESOLVES ON A FULLY SECURED RIGHTS ISSUE OF
APPROXIMATELY
SEK 151 MILLION
* PURPOSE IS TO FINANCE CONTINUED DEVELOPMENT OF COMPANY AND
PROJECTS IN ACCORDANCE WITH BUSINESS PLAN AND STRATEGY
* SUBSCRIPTION PRICE HAS BEEN SET TO SEK 1.68 PER SHARE
* ASSUMING THAT RIGHTS ISSUE IS FULLY SUBSCRIBED, AMOUNTS TO
ISSUE
PROCEEDS OF APPROXIMATELY SEK 151 MILLION BEFORE DEDUCTION OF
ISSUE COSTS.
* SUBSCRIPTION PERIOD RUNS FROM 8 MARCH 2022 THROUGH 22
MARCH
2022.
* RIGHTS ISSUE COMPRISES A MAXIMUM OF 89,673,909 SHARES
Source text for Eikon: ID:nMFNjVvdt
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))